FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Leif Spange Mortensen

Research Profile

Disorders

Geographic Areas

Denmark

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Procedures

Objects

Coronary Care Units

Co-author Network

Publications

TOP 3
Jesper Hastrup Svendsen; Henning Rud Andersen; Stine Darkner; Gunnar V H Jensen; Leif Spange Mortensen; Jens Cosedis Nielsen
CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome.
Jens Cosedis Nielsen; Leif Spange Mortensen; Peter Steen Hansen
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
Martin Busk; F P D'Andrea; K V Hansen; Steen Jakobsen; J F Kallehauge; Leif Spange Mortensen; Marianne Nordsmark; Jens Overgaard; Torben Steiniche; J Theil; Michael R Horsman
PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Leif Spange Mortensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jesper Hastrup Svendsen; Henning Rud Andersen; Stine Darkner; Gunnar V H Jensen; Leif Spange Mortensen; Jens Cosedis Nielsen
CHADS2 and CHA2DS2-VASc score to assess risk of stroke and death in patients paced for sick sinus syndrome.
Heart (British Cardiac Society) 2013;99(12):843-8.
2013: Jens Cosedis Nielsen; Leif Spange Mortensen; Peter Steen Hansen
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
The New England journal of medicine 2013;368(5):478-9.
2013: Martin Busk; F P D'Andrea; K V Hansen; Steen Jakobsen; J F Kallehauge; Leif Spange Mortensen; Marianne Nordsmark; Jens Overgaard; Torben Steiniche; J Theil; Michael R Horsman
PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
European journal of nuclear medicine and molecular imaging 2013;40(2):186-97.
2012: Jens Cosedis Nielsen; Anders Englund; Juha Hartikainen; Gerhard Hindricks; Arne Johannessen; Ole Kongstad; Leif Spange Mortensen; Steen Pehrson; Pekka Raatikainen; Håkan Walfridsson; Peter Steen Hansen
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
The New England journal of medicine 2012;367(17):1587-95.
2012: Jens Cosedis Nielsen; Tonny Nielsen; Sam Riahi; Erik H Simonsen; Jesper H Svendsen; P E B Thomsen; William D Toff; Henning R Andersen; Mogens Asklund; Per Dahl Christensen; Dorthe Dalsgaard; Ulrik H Eriksen; Elsebeth V Friis; Jeff S Healey; Søren Højberg; Gunnar V H Jensen; Mogens Møller; Leif Spange Mortensen
Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(5):682-9.
2011: Jens Cosedis Nielsen; P E B Thomsen; Søren Højberg; Mogens Møller; Thomas Vesterlund; Dorthe Dalsgaard; Leif Spange Mortensen; Tonny Nielsen; Mogens Asklund; Elsebeth V Friis; Per Dahl Christensen; Erik H Simonsen; Ulrik H Eriksen; Gunnar V H Jensen; Jesper H Svendsen; William D Toff; Jeffrey S Healey; Henning Rud Andersen
A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome.
European heart journal 2011;32(6):686-96.
2011: James Heaf; Leif Spange Mortensen
Uraemia progression in chronic kidney disease stages 3-5 is not constant.
Nephron. Clinical practice 2011;118(4):c367-74.
2010: Michael Maeng; Peter Haubjerg Nielsen; Martin Busk; Leif Spange Mortensen; Steen Dalby Kristensen; Torsten Toftegaard Nielsen; Henning Rud Andersen
Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
The American journal of cardiology 2010;105(11):1528-34.
2009: Martin Busk; Michael Maeng; Steen Dalby Kristensen; Leif Thuesen; Lars Romer Krusell; Leif Spange Mortensen; Ebbe R Steinmetz; Torsten T Nielsen; Henning Rud Andersen
Timing, causes, and predictors of death after three years' follow-up in the Danish Multicenter Randomized Study of Fibrinolysis versus Primary Angioplasty in Acute Myocardial Infarction (DANAMI-2) trial.
The American journal of cardiology 2009;104(2):210-5.
2009: Christian Jons; Peter Steen Hansen; Arne Johannessen; Gerd Hindricks; Pekka Raatikainen; Ole Kongstad; Håkan Walfridsson; Steen Pehrson; Henrik Almroth; Juha Hartikainen; Anders Kirstein Petersen; Leif Spange Mortensen; Jens Cosedis Nielsen
The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: clinical rationale, study design, and implementation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2009;11(7):917-23.
2009: Martin Busk; Steen Dalby Kristensen; Klaus Rasmussen; Henning Kelbaek; Per Thayssen; Jan Kyst Madsen; Ulrik Abildgaard; Lars Romer Krusell; Leif Spange Mortensen; Leif Thuesen; Henning Rud Andersen; Torsten T Nielsen
Clinical reinfarction according to infarct location and reperfusion modality in patients with ST elevation myocardial infarction. A DANAMI-2 long-term follow-up substudy.
Cardiology 2009;113(1):72-80.
2008: Emil Loldrup Fosbøl; Jens jakob Thune; Henning Kelbaek; Henning Rud Andersen; Kari Saunamäki; Torsten Toftegaard Nielsen; Leif Spange Mortensen; Lars Køber
Long-term outcome of primary angioplasty compared with fibrinolysis across age groups: a Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2) substudy.
American heart journal 2008;156(2):391-6.
2007: Lars Frost; Ljubica Vukelic Andersen; Søren P Johnsen; Leif Spange Mortensen
Lost life years attributable to stroke among patients with nonvalvular atrial fibrillation: a nationwide population-based follow-up study.
Neuroepidemiology 2007;29(1-2):59-65.
2007: Lars Frost; Ljubica Vukelic Andersen; John Godtfredsen; Leif Spange Mortensen
Age and risk of stroke in atrial fibrillation: evidence for guidelines?
Neuroepidemiology 2007;28(2):109-15.
2007: Lars Frost; Ljubica Vukelic Andersen; Peter Vestergaard; Steen E Husted; Leif Spange Mortensen
Trend in mortality after stroke with atrial fibrillation.
The American journal of medicine 2007;120(1):47-53.
2006: Maria Sejersten; Rasmus Sejersten Ripa; Charles Maynard; Galen S Wagner; Henning Rud Andersen; Peer Grande; Leif Spange Mortensen; Peter Clemmensen
Usefulness of quantitative baseline ST-segment elevation for predicting outcomes after primary coronary angioplasty or fibrinolysis (results from the DANAMI-2 trial).
The American journal of cardiology 2006;97(5):611-6.
2006: Henrik K Kjaergard; Per Hostrup Nielsen; Jan Jesper Andreasen; Daniel A Steinbrüchel; Lars Ib Andersen; Klaus Rasmussen; Henning Rud Andersen; Torsten Toftegaard Nielsen; Leif Spange Mortensen
Coronary artery bypass grafting within the first year after treatment of large acute myocardial infarctions with angioplasty or fibrinolysis.
Scandinavian cardiovascular journal : SCJ 2006;40(1):25-8.
2006: Lars Frost; Ljubica Vukelic Andersen; Leif Spange Mortensen; Claus Dethlefsen
Seasonal variation in stroke and stroke-associated mortality in patients with a hospital diagnosis of nonvalvular atrial fibrillation or flutter. A population-based study in Denmark.
Neuroepidemiology 2006;26(4):220-5.
2006: Lars Frost; Ljubica Vukelic Andersen; Peter Vestergaard; Steen E Husted; Leif Spange Mortensen
Trends in risk of stroke in patients with a hospital diagnosis of nonvalvular atrial fibrillation: National Cohort Study in Denmark, 1980-2002.
Neuroepidemiology 2006;26(4):212-9.
2005: Jens jakob Thune; Dan Eik Hoefsten; Matias Greve Lindholm; Leif Spange Mortensen; Henning Rud Andersen; Torsten Toftegaard Nielsen; Lars Kober; Henning Kelbaek
Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty.
Circulation 2005;112(13):2017-21.
2005: Lars Frost; Peter Vestergaard; Leif Mosekilde; Leif Spange Mortensen
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999.
International journal of cardiology 2005;103(1):78-84.
2003: Henning Rud Andersen; Torsten Toftegaard Nielsen; Klaus Rasmussen; Leif Thuesen; Henning Kelbaek; Per Thayssen; Ulrik Abildgaard; Flemming Pedersen; Jan Kyst Madsen; Peer Grande; Anton B Villadsen; Lars Romer Krusell; Torben Haghfelt; Preben Lomholt; Steen E Husted; Else Vigholt; Henrik K Kjaergard; Leif Spange Mortensen
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
The New England journal of medicine 2003;349(8):733-42.
2003: Henning Rud Andersen; Torsten Toftegaard Nielsen; Thomas Vesterlund; Peer Grande; Ulrik Abildgaard; Per Thayssen; Flemming Pedersen; Leif Spange Mortensen
Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).
American heart journal 2003;146(2):234-41.
2001: M Vaage-Nilsen; Verner Rasmussen; G Jensen; L Simonsen; Leif Spange Mortensen
Recovery of autonomic nervous activity after myocardial infarction demonstrated by short-term measurements of SDNN.
Scandinavian cardiovascular journal : SCJ 2001;35(3):186-91.
2000: Ahmad Sajadieh; Jørgen Fischer Hansen; Leif Spange Mortensen
[Prognosis after late versus early nonfatal myocardial infarction].
Ugeskrift for laeger 2000;162(6):778-81.
1999: Ahmad Sajadieh; O Wendelboe; Jørgen Fischer Hansen; Leif Spange Mortensen
Nonsteroidal anti-inflammatory drugs after acute myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.
The American journal of cardiology 1999;83(8):1263-5, A9.
1998: Ahmad Sajadieh; Jørgen Fischer Hansen; Leif Spange Mortensen
Temporal pattern of the effect of verapamil on myocardial reinfarction. DAVIT Study Group. Danish Verapamil Infarction Trial.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1998;12(4):405-8.
1998: Ahmad Sajadieh; Jørgen Fischer Hansen; Leif Spange Mortensen
Comparison of the prognosis after early versus late recurrent nonfatal myocardial infarction. DAVIT Study Group. Danish Verapamil Infarction Trial.
American heart journal 1998;136(1):164-8.
1998: Søren Galatius; Jeppe Launbjerg; Leif Spange Mortensen; Jørgen Fischer Hansen
5993 survivors of suspected myocardial infarction. 10 year incidence of later myocardial infarction and subsequent mortality.
European heart journal 1998;19(4):564-9.
1997: S Galatlus-Jensen; Jeppe Launbjerg; Leif Spange Mortensen; Jørgen Fischer Hansen
[Prognosis after AMI--are there gender differences?].
Ugeskrift for laeger 1997;159(25):3951-5.
1997: Jørgen Fischer Hansen; L Hagerup; BM Sigurd; Flemming Pedersen; K Mellemgaard; O Pedersen-Bjergaard; Leif Spange Mortensen
Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
The American journal of cardiology 1997;79(6):738-41.
1996: S Galatius-Jensen; Jeppe Launbjerg; Leif Spange Mortensen; Jørgen Fischer Hansen
Sex related differences in short and long-term prognosis after acute myocardial infarction: 10 year follow up of 3073 patients in database of first Danish Verapamil Infarction Trial.
BMJ (Clinical research ed.) 1996;313(7050):137-40.
1995: Jeppe Launbjerg; P Fruergaard; J K Madsen; Leif Spange Mortensen; Jørgen Fischer Hansen
[10-year mortality of patients admitted to coronary units with or without confirmed diagnosis of myocardial infarction. A relation to anamnesis and diagnosis at discharge].
Ugeskrift for laeger 1995;157(27):3894-7.
1994: Jeppe Launbjerg; P Fruergaard; J K Madsen; Leif Spange Mortensen; Jørgen Fischer Hansen
Ten year mortality in patients with suspected acute myocardial infarction.
BMJ (Clinical research ed.) 1994;308(6938):1196-9.
1994: Jeppe Launbjerg; P Fruergaard; J K Madsen; Leif Spange Mortensen; Jørgen Fischer Hansen
Ten-year mortality of patients admitted to coronary care units with and without myocardial infarction. Risk factors from medical history and diagnosis at discharge. DAVIT-Study Group. Danish Verapamil Infarction Trial.
Cardiology 1994;85(3-4):259-66.